Cohort Company News - MedTech Innovator

Gauss Partners with Evive to Launch Mobile App for COVID-19 Testing and Research

DateApr 16 2020

Gauss, a leading developer of digital decision-support tools for the medical frontlines, in partnership with Evive, the leader in enterprise communications and benefits engagement, has today announced the nationwide release of Apollo, a free Apple iOS app and WebApp, to help increase safety and efficiency of drive-through COVID-19 screening and testing for patients and health workers. The app will also facilitate Stanford Medicine’s Apollo COVID-19 Screening Survey (Apollo Study). Apollo helps people determine if they are likely to qualify for COVID-19 testing based on CDC guidelines and helps them find a nearby testing facility from a nationwide directory.

Hillel’s Tech Corner: Clues to the COVID-19 crisis

DateApr 10 2020

CLEW Medical are literally navigating the maze of patient data providing clues where they are most needed and where there would otherwise be none.

Carnation Ambulatory Monitor patch used to detect arrhythmias in COVID-19 patients

DateApr 09 2020

Bardy Diagnostics has announced that its Carnation Ambulatory Monitor (CAM) Patch has been chosen for use in protocols to measure QT Segments in COVID-19 patients who have been prescribed hydroxychloroquine (HCQ). BardyDx’s CAM Patch will be utilised in newly established protocols at hospitals across the Seattle area to monitor cardiac rhythms for COVID-19 patients on HCQ after hospital discharge, as well as for outpatients.

SilverCloud Health Raises $16M in Series B Funding

DateApr 08 2020

The company intends to use the funds to further expand program offerings in North America, enhance the current global portfolio, and conduct additional research and clinical trials. The company’s mental health programs are currently used globally by more than 300 organizations and by more than 350,000 users.

Nanomix Awarded BARDA Contract for Development of Rapid, Mobile, Point-of-Care Assays to Detect COVID-19 Infection

DateApr 08 2020

Nanomix, a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that the company has been awarded up to approximately $570,000 in funding from Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. These funds support development and testing of COVID-19 point-of-care tests that will run on the Nanomix eLab analyzer, which provides results in less than 15 minutes.

Spire Health Helps Pulmonary, Critical Care & Sleep Disorders Institute of South Florida Remotely Monitor High Risk Patients in Fight Against Coronavirus

DateApr 02 2020

Spire Health, the leading digital healthcare company for continuous respiratory remote patient monitoring, and PCSI, a large outpatient pulmonary group in the Palm Beach area of Florida, announced today a collaborative partnership to remotely monitor chronic respiratory disease patients from home in an effort to help PCSI healthcare providers detect early signs of COVID-19 and limit exposure for healthy patients.

OrthoPediatrics Corp. Announces Acquisition of ApiFix Ltd. with FDA-Approved Non-Fusion Scoliosis Technology

DateApr 01 2020

Mark Throdahl, President and Chief Executive Officer of OrthoPediatrics, commented, “We believe that ApiFix fills a major treatment gap that could potentially allow patients to avoid fusion surgery. We estimate that non-fusion procedures will grow significantly as patients, their families, and surgeons recognize non-fusion’s benefits."

Selective endovascular cooling with TwinFlo catheter shows promise for neuroprotection in stroke patients

DateMar 27 2020

Ron Solar and colleagues report in EuroIntervention that the TwinFlo catheter (ThermopeutiX), in pigs, was associated with rapid, selective, deep cerebral hypothermia. They add that the catheter may “offer an improved method for neuroprotection during neurosurgery, cardiac arrest, acute stroke, and other ischaemic insult”. Solar talks to BIBA Briefings about the role of hypothermia in neuroprotection.

Bardy Diagnostics™ Announces Use of The Carnation Ambulatory Monitor Patch to Measure QT Segments in COVID-19 Patients Using Hydroxychloroquine

DateMar 25 2020

SEATTLE, March 25, 2020 /PRNewswire/ — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that its Carnation Ambulatory...

Duo device for tricuspid repair records first successful use in humans

DateMar 23 2020

CroíValve has announced the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The company says the procedure was performed by an experienced heart team in St James’ University Hospital (Dublin, Ireland).

Duo device for tricuspid repair records first successful use in humans

DateMar 23 2020

CroíValve has announced the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The company says the procedure was performed...

Spry Health Launches New Service, Loop Signal, to Assist in Surge of COVID-19 Cases by Reducing Avoidable Hospital Visits and Improving Patient Monitoring at Home

DateMar 20 2020

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Spry Health, a leader in health management technologies and remote patient monitoring, today announced the launch of Loop Signal, a new clinician-led...

Pristine Surgical completes $18 million capital raise

DateMar 17 2020

Pristine Surgical LLC, makers of the first fully-integrated, single-use visualization platform for rigid endoscopic surgical and diagnostic procedures, announced today that it completed its third round of investment capital raising. The capital round, totaling $18 million, funds the completion of the company's high-volume manufacturing capability, product launch and roadmap expansion.

Zeto Raises Series A Funding to Accelerate Commercialization Efforts of its Easy Use Electroencephalography (EEG) Headset and Software Platform

DateMar 10 2020

The new capital will be used to accelerate commercialization of its lead product, the zEEG headset and software platform, and develop new products to expand its portfolio. zEEG is the first true dry electrode EEG headset to be approved by the U.S. Food and Drug Administration (FDA) for clinical use.

Subtle Medical Named to the 2020 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

DateMar 03 2020

"The acceptance into the CB Insights AI Top 100 list marks a tremendous milestone for Subtle Medical," said Enhao Gong, PhD, Founder/CEO of Subtle Medical. "We have graduated from a promising start-up to a commercial company deploying software products that directly add value for patients and the centers that serve them. Through our deep learning-powered software solutions for accelerated image acquisition, hospitals and imaging centers can reap impressive efficiency gains while improving patient satisfaction. We are honored to be mentioned among this elite class of companies using AI to improve healthcare."

Abreos gets Grant of 850 000 USD for monitoring of Crohns disease

DateFeb 25 2020

Abreos Biosciences has been awarded funding for phase two of the "Personalized precision dosing of anti-TNF biological therapies" project by, among others, the National Institute of Health's (NIH). This "Fast Track Award" is the second part of a project focused on treating chronic inflammatory diseases.

ALPHASTROKE, A Better Way to Diagnose Strokes: Interview with CEO Matt Kesinger

DateFeb 25 2020

MedTech Innovator CEO Paul Grand attributes much of the company’s success in the competition to the need for a device like ALPHASTROKE. “It’s not often that you hear people who are as experienced as our selection committee saying, ‘This is a real game changer,’” he notes. “And people are saying that about Forest Devices… It’s technology that will save lives.”

Endotronix begins heart failure study with Cordella Sensor

DateFeb 19 2020

Digital health and medical technology firm Endotronix has recruited the first two patients in the PROACTIVE-HF pivotal trial of the Cordella pulmonary artery (PA) pressure sensor system.

Endotronix begins heart failure study with Cordella Sensor

DateFeb 19 2020

By NS Medical Staff Writer Digital health and medical technology firm Endotronix has recruited the first two patients in the PROACTIVE-HF pivotal trial of the Cordella...

2Morrow Distributes Digital Health Programs Aimed at Smoking and Vaping Cessation on Walmart.com

DateFeb 19 2020

2Morrow’s program was first developed and clinically-tested in collaboration with researchers from the Fred Hutchinson Cancer Research Center and has already helped over 75,000 tobacco users with their efforts to quit. Until now, the programs have been available only via select employers, states and organizations.